Moderna and Pfizer are about to raise the price of Covid vaccines by 400 percent
- Details
- Published on Sunday, 29 November -0001 16:00
- Written by editor
This is a message from a partner organization of The Intercept and does not imply the editorial endorsement of The Intercept or any of its staff. Our partner organization will collect your name and email address if you participate in the action below.
As the U.S. plans to relinquish its role as the predominant purchaser of the Covid-19 vaccine to the commercial sector, vaccine manufacturers Moderna and Pfizer have announced plans to hike the price of the vaccine by over 400 percent. The decision would increase the price from $26 to $110-130 per dose, despite it costing only $2.85 to produce.
Pfizer and Moderna made record-breaking profits from the Covid-19 vaccine, but taxpayers funded the development of the Covid-19 vaccines in 2020 through Operation Warp... Speed and the CARES Act.
In the case of Moderna, the pharmaceutical giant does not even have permission to use one of the key government-owned technologies behind the vaccine. Pfizer’s vaccine also derives from basic government-funded research on mRNA technology, which was funded in part by the National Institutes of Health.
The billions in profits raked in by Moderna and Pfizer would not be possible without taxpayer resources and government-funded innovation, making the moral depravity of their recent decisions that much more repugnant.
While Moderna and Pfizer continue to say the price gouging won’t impact consumers, experts argue that it will cost taxpayers billions of dollars in Medicaid and Medicare funding. People on private insurance can also expect to see their premiums go up. Most significantly, the impact will be felt by those without health insurance. This type of corporate price gouging from Pfizer and Moderna will inevitably result in lower vaccination rates and increased risk to global health.
The federal government arguably has authority over the pricing of products developed through federal funds. If pharmaceutical companies want to continue to callously threaten public health in an effort to price gouge life-saving products, the U.S. government has a responsibility to check them accordingly.
First Look Institute is a 501(c)(3) charitable organization (tax ID number 80-0951255).
The Intercept’s mailing address is:
First Look Institute
P.O. Box 27442
Washington, DC 20038
The Intercept is an award-winning nonprofit news organization dedicated to holding the powerful accountable through fearless, adversarial journalism. Our in-depth investigations and unflinching analysis focus on surveillance, war, corruption, the environment, technology, criminal justice, the media and more. Email is an important way for us to communicate with The Intercept’s readers, but if you’d like to stop hearing from us, click here to r0 from all communications. Protecting freedom of the press has never been more important. Contribute now to support our independent journalism.
